RxDoctor Payments Data

Robert Penney

Obstetrics & Gynecology · Holmdel, NJNPI 1790773653

Payments from drug & device makers

What this record shows

This record is dominated by education: $16,138 of the $18,551 with a category attached, or 87.0%. Intuitive Surgical accounts for 91.6% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2021 at $17,018 and has fallen 98.6% since, to $241 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,551in general payments, 2019–2025

Across 102 payments — averaging $181.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$17K
  • Astellas Pharma US Inc$210
  • Medtronic$117
  • AbbVie$106
  • Mayne Pharma Commercial LLC$91
  • Dysis Medical, Inc.$79
  • plus $948 from 27 others

What the payments were for

  • Consulting fees$190%
  • Food & beverage$2,39413%
  • Education$16,13887%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,551 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$19,214
Medicare patients
125
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$2,501
Estradiol51$1,474
Ibandronate Sodium20$603
Alendronate Sodium92$459
Medroxyprogesterone Acetate17$165
Fluoxetine Hcl14$90

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$57$2,50112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

Other obstetrics & gynecology in Holmdel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →